Home > Healthcare > Medical Devices > Therapeutic Devices > Topical Wound Agents Market
Topical Wound Agents Market Share
- Report ID: GMI7712
- Published Date: Dec 2023
- Report Format: PDF
Topical Wound Agents Market Share
The topical wound agents industry is consolidated, with key players including Smith & Nephew Plc., Teva Pharmaceutical Industries Ltd, Mylan N.V., AstraZeneca, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial position in the market. For instance, in February 2023, SERDA Therapeutics, a biopharmaceutical company, announced the submission of an Investigational New Drug Application (IND) to the U.S. FDA for its flagship product, SN514 hydrogel. SN514 hydrogel is a groundbreaking enzymatic wound debriding agent developed by the company. This move substantially broadened company’s array of products, leading to increased revenue streams for the company.
Topical Wound Agents Market Companies
Some of the eminent market participants operating in the topical wound agents industry include:
- Smith & Nephew plc
- Teva Pharmaceutical Industries Ltd.
- Mölnlycke Health Care AB
- Arch Therapeutics, Inc.
- Mylan N.V.
- AstraZeneca
- Osiris Therapeutics, Inc.
- 3M Company
- Coloplast A/S
- Medline Industries, Inc.
- B. Braun Melsungen AG
- Integra LifeSciences Corporation
- Paul Hartmann AG
- SERDA Therapeutics
- Bausch Health Companies Inc.
Frequently Asked Questions (FAQ) :
Topical Wound Agents Market Scope
